Search Results - "López-Riera M"

Guazuma ulmifolia butanol extract protects against cadmium-induced hepatotoxicity via HO-1/Sirt-1 activation, miRNA–lncRNA modulation, and metabolic reprogramming.

Authors: Elsabagh, Osama Ahmed Elgamal, Abdelbaset M. Hassan, Heba A. et al.

Source: PLoS ONE. 8/6/2026, Vol. 21 Issue 8, p1-31. 31p.

Drug-Induced Liver Injury: Role of Circulating Liver-Specific microRNAs and Keratin-18.

Authors: Cardin, Romilda Bizzaro, Debora Russo, Francesco Paolo et al.

Source: Gastroenterology Insights. Dec2024, Vol. 15 Issue 4, p1093-1105. 13p.

miRNAs, lncRNAs, circRNAs and piRNAs in Nonalcoholic Fatty Liver Disease: Past, Present and Future.

Authors: Lucaciu, Roxana Liana Orasan, Olga Hilda Hangan, Adriana Corina et al.

Source: International Journal of Molecular Sciences. Nov2025, Vol. 26 Issue 21, p10402. 42p.

The miR-122 inhibition alleviates lipid accumulation and inflammation in NAFLD cell model.

Authors: Hu, Yiyi Du, Guoping Li, Guohua et al.

Source: Archives of Physiology & Biochemistry. Oct2021, Vol. 127 Issue 5, p385-389. 5p.

The Integrated Bioinformatic Assay of Genetic Expression Features and Analyses of Traditional Chinese Medicine Specific Constitution Reveal Metabolic Characteristics and Targets in Steatosis of Nonalcoholic Fatty Liver Disease.

Authors: Qiao, Chunping Gu, Chengying Wen, Song et al.

Source: Hepatic Medicine: Evidence & Research. Oct2023, Vol. 15, p165-183. 19p.

Hepatoprotective effects of Nigella Sativa oil against acrylamide-induced liver injury in rats.

Authors: HATİPOĞLU, Durmuş ÖZSAN, Mehmet DÖNMEZ, Hasan Hüseyin et al.

Source: Veterinary Journal of Ankara University / Ankara Universitesi Veteriner Fakultesi Dergisi. 2023, Vol. 70 Issue 4, p419-426. 8p.

Atherosclerosis and Other Related-Arterial Diseases.

Authors: Blanco-Colio, Luis M. Martín-Ventura, Jose L.

Source: International Journal of Molecular Sciences. Jul2023, Vol. 24 Issue 13, p10453. 3p.

Optimal endogenous controls for microRNA analysis of visceral adipose tissue in the NAFLD mouse model: Endogenous miRNA controls in NAFLD adipose tissue: Veronika Uhrova et al.

Authors: Uhrova, Veronika Parova, Helena Cervinkova, Zuzana et al.

Source: Journal of Biosciences. Mar2025, Vol. 50 Issue 1, p1-14. 14p.

The Role of microRNA-22 in Metabolism.

Authors: Tomasini, Simone Vigo, Paolo Margiotta, Francesco et al.

Source: International Journal of Molecular Sciences. Jan2025, Vol. 26 Issue 2, p782. 21p.

Recent Advances in miRNA-Based Therapy for MASLD/MASH and MASH-Associated HCC.

Authors: Carpi, Sara Daniele, Simona de Almeida, Jacqueline Fátima Martins et al.

Source: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p12229. 17p.

The Development of a Non-Invasive Screening Method Based on Serum microRNAs to Quantify the Percentage of Liver Steatosis.

Authors: Soluyanova, Polina Quintás, Guillermo Pérez-Rubio, Álvaro et al.

Source: Biomolecules (2218-273X). Nov2024, Vol. 14 Issue 11, p1423. 18p.

Systems analysis of miRNA biomarkers to inform drug safety.

Authors: Schofield, Amy L. Brown, Joseph P. Brown, Jack et al.

Source: Archives of Toxicology. Nov2021, Vol. 95 Issue 11, p3475-3495. 21p.

Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights.

Authors: Aggeletopoulou, Ioanna Tsounis, Efthymios P. Triantos, Christos

Source: International Journal of Molecular Sciences. May2024, Vol. 25 Issue 9, p4901. 21p.

Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis.

Authors: Xin, Shengliang Zhan, Qiao Chen, Xiaofan et al.

Source: BMC Gastroenterology. 6/12/2020, Vol. 20 Issue 1, p1-14. 14p. 1 Diagram, 1 Chart, 5 Graphs.

Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.

Authors: Erhartova, Denisa Cahova, Monika Dankova, Helena et al.

Source: PLoS ONE. 11/8/2019, Vol. 14 Issue 11, p1-14. 14p.

miR-27b targets MAIP1 to mediate lipid accumulation in cultured human and mouse hepatic cells.

Authors: Sakai, Eiko Imaizumi, Tsutomu Suzuki, Ruruka et al.

Source: Communications Biology. 6/24/2023, Vol. 6 Issue 1, p1-14. 14p.

MicroRNA-483-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Cell Steatosis, and Fibrosis by Targeting PPARα and TIMP2.

Authors: Niture, Suryakant Gadi, Sashi Qi, Qi et al.

Source: Cancers. Mar2023, Vol. 15 Issue 6, p1715. 21p.

Quantification of microRNA in plasma using probe based TaqMan assays: is microRNA purification required?

Authors: Binderup, Helle Glud Madsen, Jonna Skov Brasen, Claus Lohman et al.

Source: BMC Research Notes. 5/10/2019, Vol. 12 Issue 1, p1-5. 5p. 2 Charts, 1 Graph.

Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets.

Authors: Kazeminasab, Fatemeh Baharlooie, Maryam Ghaedi, Kamran

Source: PPAR Research. 9/17/2022, Vol. 2022, p1-13. 13p.

Activation of the Constitutive Androstane Receptor Inhibits Leukocyte Adhesiveness to Dysfunctional Endothelium.

Authors: López-Riera, Mireia Ortega, Rebeca Hueso, Luisa et al.

Source: International Journal of Molecular Sciences. Sep2021, Vol. 22 Issue 17, p9267. 1p.